Measuring IGF-1 and IGFBP-3 Profiles in Women Seeking Assisted Reproduction; Relationship to Clinical Parameters (Study 1)

por Yovich, John L., Zaidi, Syeda, Nguyen, Minh D. K., Hinchliffe, Peter M.
Publicado 2020

Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis

por Keane, Kevin N, Yovich, John L, Hamidi, Anahita, Hinchliffe, Peter M, Dhaliwal, Satvinder S
Publicado 2017

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome

por Yovich, John L, Alsbjerg, Birgit, Conceicao, Jason L, Hinchliffe, Peter M, Keane, Kevin N
Publicado 2016

Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization

por Keane, Kevin N, Hinchliffe, Peter M, Namdar, Navid, Conceicao, Jason L, Newsholme, Philip, Yovich, John L
Publicado 2015

Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis

por Keane, Kevin N, Ye, Yun, Hinchliffe, Peter M, Regan, Sheena LP, Dhaliwal, Satvinder S, Yovich, John L
Publicado 2019

DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis

por Keane, Kevin N., Hinchliffe, Peter M., Rowlands, Philip K., Borude, Gayatri, Srinivasan, Shanti, Dhaliwal, Satvinder S., Yovich, John L.
Publicado 2018